Found: 8
Select item for more details and to access through your institution.
Human Soluble CD80 is Generated by Alternative Splicing, and Recombinant Soluble CD80 Binds to CD28 and CD152 Influencing T-cell Activation.
- Published in:
- Scandinavian Journal of Immunology, 2007, v. 66, n. 5, p. 529, doi. 10.1111/j.1365-3083.2007.02009.x
- By:
- Publication type:
- Article
Radon Survey in Kalamata (Greece).
- Published in:
- Radiation Protection Dosimetry, 2001, v. 93, n. 1, p. 75, doi. 10.1093/oxfordjournals.rpd.a006416
- By:
- Publication type:
- Article
Preliminary Radon Survey in Greece.
- Published in:
- Radiation Protection Dosimetry, 1999, v. 81, n. 4, p. 305, doi. 10.1093/oxfordjournals.rpd.a032599
- By:
- Publication type:
- Article
CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis.
- Published in:
- Genes & Immunity, 2002, v. 3, n. 1, p. 46, doi. 10.1038/sj.gene.6363816
- By:
- Publication type:
- Article
The soluble forms of CD28, CD86 and CTLA-4 constitute possible immunological markers in patients with abdominal aortic aneurysm.
- Published in:
- Journal of Internal Medicine, 2007, v. 261, n. 4, p. 399, doi. 10.1111/j.1365-2796.2007.01773.x
- By:
- Publication type:
- Article
Characterization of the expanded T-cell populations in patients with Wegener's granulomatosis.
- Published in:
- Journal of Internal Medicine, 2006, v. 260, n. 3, p. 224, doi. 10.1111/j.1365-2796.2006.01688.x
- By:
- Publication type:
- Article
Treatment of a patient with myasthenia gravis using antibodies against CD25.
- Published in:
- Acta Neurologica Scandinavica, 2008, v. 117, n. 3, p. 211, doi. 10.1111/j.1600-0404.2007.00919.x
- By:
- Publication type:
- Article
A clinical and immunological study of a myasthenia gravis patient treated with infliximab.
- Published in:
- Acta Neurologica Scandinavica, 2007, v. 115, n. 4, p. 279, doi. 10.1111/j.1600-0404.2006.00778.x
- By:
- Publication type:
- Article